Finanzas

Samsung Biologics es investigada por valorar IPO en US$2 mil millones

Samsung Biologics enfrenta investigación.
Comentarios (0)

Responder

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.